{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T18:26:57Z","timestamp":1793471217028,"version":"4.5.0"},"reference-count":30,"publisher":"Japan Surgical Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Surg Case Rep"],"published-print":{"date-parts":[[2025]]},"DOI":"10.70352\/scrj.cr.25-0645","type":"journal-article","created":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T22:09:04Z","timestamp":1766009344000},"page":"n\/a","source":"Crossref","is-referenced-by-count":1,"title":["Immune Checkpoint Inhibition as a Novel Strategy for Microsatellite Instability-High Duodenal Adenocarcinoma: A Report of Three Cases"],"prefix":"10.70352","volume":"11","author":[{"given":"Kojiro","family":"Shirabe","sequence":"first","affiliation":[{"name":"Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuro","family":"Kawazoe","sequence":"additional","affiliation":[{"name":"Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoya","family":"Harima","sequence":"additional","affiliation":[{"name":"Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sho","family":"Nambara","sequence":"additional","affiliation":[{"name":"Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuo","family":"Tsuda","sequence":"additional","affiliation":[{"name":"Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomonori","family":"Nakanoko","sequence":"additional","affiliation":[{"name":"Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Ando","sequence":"additional","affiliation":[{"name":"Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiji","family":"Oki","sequence":"additional","affiliation":[{"name":"Department of Advanced Medicine and Innovative Technology, Kyushu University Hospital, Fukuoka, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoharu","family":"Yoshizumi","sequence":"additional","affiliation":[{"name":"Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"51119","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Goldner B, Stabile BE. Duodenal adenocarcinoma: why the extreme rarity of duodenal bulb primary tumors? Am Surg 2014; 80: 956\u20139.","DOI":"10.1177\/000313481408001010"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Yamamoto T, Takahashi A, Yoshizumi T, et al. 2023 National Clinical Database Annual Report by the Japan Surgical Society. Surg Today 2025; 55: 295\u2013334.","DOI":"10.1007\/s00595-024-02980-1"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Colina A, Hwang H, Wang H, et al. Natural history and prognostic factors for localised small bowel adenocarcinoma. ESMO Open 2020; 5: e000960.","DOI":"10.1136\/esmoopen-2020-000960"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Maio M, Ascierto PA, Manzyuk L, et al. Pembrolizumab in microsatellite instability high or mismatch repair deficient cancers: updated analysis from the phase II KEYNOTE-158 study. Ann Oncol 2022; 33: 929\u201338.","DOI":"10.1016\/j.annonc.2022.05.519"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Pedersen KS, Foster NR, Overman MJ, et al. ZEBRA: A multicenter phase II study of pembrolizumab in patients with advanced small-bowel adenocarcinoma. Clin Cancer Res 2021; 27: 3641\u20138.","DOI":"10.1158\/1078-0432.CCR-21-0159"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Itatani Y, Yamamoto T, Zhong C, et al. Suppressing neutrophil-dependent angiogenesis abrogates resistance to anti-VEGF antibody in a genetic model of colorectal cancer. Proc Natl Acad Sci USA 2020; 117: 21598\u2013608.","DOI":"10.1073\/pnas.2008112117"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Brierley JD, Gospodarowicz MK, Wittekind C. TNM classification of malignant tumours: John Wiley & Sons; 2017.","DOI":"10.1002\/9780471420194.tnmc26.pub3"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Qubaiah O, Devesa SS, Platz CE, et al. Small intestinal cancer: a population-based study of incidence and survival patterns in the United States, 1992 to 2006. Cancer Epidemiol Biomarkers Prev 2010; 19: 1908\u201318.","DOI":"10.1158\/1055-9965.EPI-10-0328"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Bojesen RD, Andersson M, Riis LB, et al. Incidence of, phenotypes of and survival from small bowel cancer in Denmark, 1994\u20132010: a population-based study. J Gastroenterol 2016; 51: 891\u20139.","DOI":"10.1007\/s00535-016-1171-7"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Lu Y, Fr\u00f6bom R, Lagergren J. Incidence patterns of small bowel cancer in a population-based study in Sweden: increase in duodenal adenocarcinoma. Cancer Epidemiol 2012; 36: e158\u201363.","DOI":"10.1016\/j.canep.2012.01.008"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Nakagawa K, Sho M, Fujishiro M, et al. Clinical practice guidelines for duodenal cancer 2021. J Gastroenterol 2022; 57: 927\u201341.","DOI":"10.1007\/s00535-022-01919-y"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Akagi K, Oki E, Taniguchi H, et al. Real-world data on microsatellite instability status in various unresectable or metastatic solid tumors. Cancer Sci 2021; 112: 1105\u201313.","DOI":"10.1111\/cas.14798"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Rostain F, Hamza S, Drouillard A, et al. Trends in incidence and management of cancer of the ampulla of Vater. World J Gastroenterol 2014; 20: 10144\u201350.","DOI":"10.3748\/wjg.v20.i29.10144"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Tang N, Chen ZY, Yang Z, et al. Development and verification of prognostic nomogram for ampullary carcinoma based on the SEER database. Front Oncol 2023; 13: 1197626.","DOI":"10.3389\/fonc.2023.1197626"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Albores-Saavedra J, Schwartz AM, Batich K, et al. Cancers of the ampulla of vater: demographics, morphology, and survival based on 5,625 cases from the SEER program. J Surg Oncol 2009; 100: 598\u2013605.","DOI":"10.1002\/jso.21374"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) de Bakker J, Biesma H, Soeratram T, et al. Molecular classification of resected primary duodenal adenocarcinoma. Genes Chromosomes Cancer 2025; 64: e70061.","DOI":"10.1002\/gcc.70061"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Ozato T, Kono Y, Horiguchi S, et al. Genomic landscape and clinical impact of homologous recombination repair gene mutation in small bowel adenocarcinoma. Eur J Cancer 2025; 220: 115401.","DOI":"10.1016\/j.ejca.2025.115401"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Andr\u00e9 T, Berton D, Curigliano G, et al. Antitumor activity and safety of dostarlimab monotherapy in patients with mismatch repair deficient solid tumors: a nonrandomized controlled trial. JAMA Netw Open 2023; 6: e2341165.","DOI":"10.1001\/jamanetworkopen.2023.41165"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Andre T, Elez E, Van Cutsem E, et al. Nivolumab plus ipilimumab in microsatellite-instability-high metastatic colorectal cancer. N Engl J Med 2024; 391: 2014\u201326.","DOI":"10.1056\/NEJMoa2402141"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Ziane Bouziane S, Mans L, Bucalau AM, et al. Neoadjuvant immunotherapy in microsatellite instability-high (MSI-H) duodenal adenocarcinoma leads to pathological complete response and paves the way for new strategies. Eur J Cancer 2024; 206: 114128.","DOI":"10.1016\/j.ejca.2024.114128"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Liu L, Kaur S, Dayyani F, et al. Medullary carcinoma of the duodenum treated with pembrolizumab: a case report. J Gastrointest Oncol 2023; 14: 1149\u201354.","DOI":"10.21037\/jgo-22-755"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Kong XL, Lu XW, Dong SQ, et al. Descending duodenal adenocarcinoma treated with pembrolizumab resulting in complete clinical response: A case report and literature review. World J Gastrointest Oncol 2025; 17: 107568.","DOI":"10.4251\/wjgo.v17.i6.107568"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Wang W, Yang Q, He Y, et al. Simultaneous double primary malignant tumors of MSS\/pMMR ascending colon cancer and MSI-H\/dMMR duodenal cancer with nearly 2 years of recurrence-free survival after MDT-guided comprehensive treatment: a case report. Front Oncol 2025; 15: 1573580.","DOI":"10.3389\/fonc.2025.1573580"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Rutkowski P, Mandala M. Perioperative therapy of melanoma: Adjuvant or neoadjuvant treatment. Eur J Surg Oncol 2024; 50: 107969.","DOI":"10.1016\/j.ejso.2024.107969"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Cui S, Wang N, Liang Y, et al. Advances in clinical trials on perioperative immune checkpoint inhibitors for resectable non-small cell lung cancer: a comprehensive review. Int Immunopharmacol 2024; 141: 112903.","DOI":"10.1016\/j.intimp.2024.112903"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Cercek A, Lumish M, Sinopoli J, et al. PD-1 blockade in mismatch repair-deficient, locally advanced rectal cancer. N Engl J Med 2022; 386: 2363\u201376.","DOI":"10.1056\/NEJMoa2201445"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Fukushima R, Harimoto N, Araki K, et al. Impact of body composition on the development of pancreatic fistula after pancreaticoduodenectomy. Surg Today 2025; 55: 1580\u20138.","DOI":"10.1007\/s00595-025-03039-5"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Koornstra JJ, Kleibeuker JH, Vasen HF. Small-bowel cancer in Lynch syndrome: is it time for surveillance? Lancet Oncol 2008; 9: 901\u20135.","DOI":"10.1016\/S1470-2045(08)70232-8"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Cohen SA, Leininger A. The genetic basis of Lynch syndrome and its implications for clinical practice and risk management. Appl Clin Genet 2014; 7: 147\u201358.","DOI":"10.2147\/TACG.S51483"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Overman MJ, Lonardi S, Wong KYM, et al. Durable clinical benefit with nivolumab plus ipilimumab in DNA mismatch repair-deficient\/microsatellite instability-high metastatic colorectal cancer. J Clin Oncol 2018; 36: 773\u20139.","DOI":"10.1200\/JCO.2017.76.9901"}],"container-title":["Surgical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/scrj\/11\/1\/11_cr.25-0645\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T04:41:54Z","timestamp":1766205714000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/scrj\/11\/1\/11_cr.25-0645\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.70352\/scrj.cr.25-0645","relation":{},"ISSN":["2198-7793"],"issn-type":[{"value":"2198-7793","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"cr.25-0645"}}